Supply Chain Management System €“ A Key Tool For The Development Of The Pharmaceutical Industry In Ukraine

The subject of this article is the supply chain management system of pharmaceu-tical industry enterprises in Ukraine. Methodology. In the course of the study, the systematic and logical approaches are mainly used. At the same time, during the study the following scientific methods were used: 1) analogy – an effective supply chain management system (hereinafter – SCM system) is defined as im-portant for enterprises of any sector of the national economy of Ukraine; 2) in-duction – significant attention is paid to the individual components and para-meters of the supply chain of the pharmaceutical industry in Ukraine; 3) generali-zation – it was found that, despite the diversity of views on the definition of SCM system, the basic idea of such a definition is identical; 4) others. The purpose of this article is to study the current state of SCM-system of pharmaceutical indus-try in Ukraine, as a key tool for its development. The results of the study show that the spread of coronavirus disease COVID-19 (hereinafter COVID-19) caused changes in the transport components of the SCM system in the enterprises of the pharmaceutical industry in Ukraine. Conclusion. The Ukrainian pharmaceutical industry is the most developed among the post-Soviet countries and has a leading position in the production of generic drugs. Thanks to the distribution of COVID-19, the industry today is the guarantor of the protection of life and health of citizens, and pharmaceutical companies receive significant profits. Giv-en today's realities, such companies continue to transform internal business pro-cesses related to the SCM system, which must first and foremost be as flexible, fast and sustainable as possible. At the same time, changes associated with the possibility of "online" sales of medicines can have a positive impact on the effec-tiveness of SCM system parameters in the pharmaceutical industry in Ukraine, which in the long term will lead to an increase in its profitability. However, such sales cannot fully guarantee high quality and safety of pharmaceutical products. Strict domestic legislation related to pharmaceutical industry regulation contrib-utes to unpredictable situations related to the SCM system. Proper identification of key priorities and anticipation of possible obstacles in advance will greatly re-duce their occurrence.